A forward genetics platform for papillomavirus research.
A phenotypic selection platform enables 2500-fold enrichment of HPV mutants, advancing genetic analysis and vaccine development.
- Why it matters: Understanding HPV genetics has been limited by the lack of forward genetics tools, hindering insights into viral mechanisms and therapeutic targets.
- What they did: The platform uses large virus libraries where each mutant encapsidates its encoding plasmid, allowing direct genotype-phenotype linkage, and successfully isolates rare mutants like antibody escape variants.
- The result: This approach reveals distinct antibody recognition patterns and opens new research pathways, facilitating improved vaccines and antiviral strategies against HPV.